Papillary thyroid carcinoma with hobnail features showing rapid progression and therapy resistance

References

• Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–1953.
   PubMed Web of Science ®Google Scholar
• Hundahl SA, Fleming ID, Fremgen AM, et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer. 1998;83(12):2638–2648.
   PubMed Web of Science ®Google Scholar
• Cameselle-Teijeiro JM, Rodríguez-Pérez I, Celestino R, et al. Hobnail variant of papillary thyroid carcinoma: clinicopathologic and molecular evidence of progression to undifferentiated carcinoma in 2 cases. Am J Surg Pathol. 2017;41(6):854–860.
   PubMed Web of Science ®Google Scholar
• Lloyd R, Osamura R, Klöppel G, et al. WHO classification of tumours of endocrine organs [Internet]. Genava (Switzerland): WHO; 2017 [cited 2020 Dec 21]. Available from: https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/WHO-Classification-Of-Tumours-Of-Endocrine-Organs-2017
   Google Scholar
• Ito Y, Hirokawa M, Hayashi T, et al. Case report: exceptionally rapid growth character of hobnail variant of papillary thyroid carcinoma: a report of four cases. Endocr J. 2020;67(10):1047–1053.
   PubMed Web of Science ®Google Scholar
• Donaldson LB, Yan F, Morgan PF, et al. Hobnail variant of papillary thyroid carcinoma: a systematic review and meta-analysis. Endocrine. 2020. doi: 10.1007/s12020-020-02505-z. Epub ahead of print. PMID: 33025563.
   PubMed Web of Science ®Google Scholar
• Asioli S, Erickson LA, Righi A, et al. Papillary thyroid carcinoma with hobnail features: histopathologic criteria to predict aggressive behavior. Hum Pathol. 2013;44(3):320–328.
   PubMed Web of Science ®Google Scholar
• Pusztaszeri M, Auger M. Update on the cytologic features of papillary thyroid carcinoma variants. Diagn Cytopathol. 2017;45(8):714–730.
   PubMed Web of Science ®Google Scholar
• Lilo MT, Bishop JA, Ali SZ. Hobnail variant of papillary thyroid carcinoma: a case with an unusual presentation. Diagn Cytopathol. 2017;45(8):754–756.
   PubMed Web of Science ®Google Scholar
• Ambrosi F, Righi A, Ricci C, et al. Hobnail variant of papillary thyroid carcinoma: a literature review. Endocr Pathol. 2017;28(4):293–301.
   PubMed Web of Science ®Google Scholar
• Agarwal S, Sadiq Q, Ortanca I. Hobnail cells in encapsulated papillary thyroid carcinoma: report of 2 cases with immunohistochemical and molecular findings and literature analysis. Pathol Res Pract. 2020;216(3):152678.
   PubMed Web of Science ®Google Scholar
• Asioli S, Erickson LA, Sebo TJ, et al. Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases. Am J Surg Pathol. 2010;34(1):44–52.
   PubMed Web of Science ®Google Scholar
• Asioli S, Maletta F, Pagni F, et al. Cytomorphologic and molecular features of hobnail variant of papillary thyroid carcinoma: case series and literature review. Diagn Cytopathol. 2014;42(1):78–84.
   PubMed Web of Science ®Google Scholar
• Ohori NP, Schoedel KE. Cytopathology of high-grade papillary thyroid carcinomas: tall-cell variant, diffuse sclerosing variant, and poorly differentiated papillary carcinoma. Diagn Cytopathol. 1999;20(1):19–23.
   PubMed Web of Science ®Google Scholar
• Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.
   PubMed Web of Science ®Google Scholar
• Kakudo K, Tang W, Ito Y, et al. Papillary carcinoma of the thyroid in Japan: subclassification of common type and identification of low risk group. J Clin Pathol. 2004;57(10):1041–1046.
   PubMed Web of Science ®Google Scholar
• Motosugi U, Murata SI, Nagata K, et al. Thyroid papillary carcinoma with micropapillary and hobnail growth pattern: a histological variant with intermediate malignancy? Thyroid. 2009;19(5):535–537.
   PubMed Web of Science ®Google Scholar
• Lubitz CC, Sosa JA. The changing landscape of papillary thyroid cancer: epidemiology, management, and the implications for patients. Cancer. 2016;122(24):3754–3759.
   PubMed Web of Science ®Google Scholar
• Morandi L, Righi A, Maletta F, et al. Somatic mutation profiling of hobnail variant of papillary thyroid carcinoma. Endocr Relat Cancer. 2017;24(2):107–117.
   PubMed Web of Science ®Google Scholar
• Bellevicine C, Cozzolino I, Malapelle U, et al. Cytological and molecular features of papillary thyroid carcinoma with prominent hobnail features: a case report. Acta Cytol. 2012;56(5):560–564.
   PubMed Web of Science ®Google Scholar
• Yang GCH, Fried K, Scognamiglio T. Cytological features of clear cell thyroid tumors, including a papillary thyroid carcinoma with prominent hobnail features. Diagn Cytopathol. 2013;41(9):757–761.
   PubMed Web of Science ®Google Scholar
• Ieni A, Barresi V, Cardia R, et al. The micropapillary/hobnail variant of papillary thyroid carcinoma: a review of series described in the literature compared to a series from one southern Italy pathology institution. Rev Endocr Metab Disord. 2016;17(4):521–527.
   PubMed Web of Science ®Google Scholar
• Lee YS, Kim Y, Jeon S, et al. Cytologic, clinicopathologic, and molecular features of papillary thyroid carcinoma with prominent hobnail features: 10 case reports and systematic literature review. Int J Clin Exp Pathol. 2015;8(7):7988–7997.
   PubMed Web of Science ®Google Scholar
• Lee SH, Jung CK, Bae JS, et al. Liquid-based cytology improves preoperative diagnostic accuracy of the tall cell variant of papillary thyroid carcinoma. Diagn Cytopathol. 2014;42(1):11–17.
   PubMed Web of Science ®Google Scholar
• Wong KS, Chen TY, Higgins SE, et al. A potential diagnostic pitfall for hobnail variant of papillary thyroid carcinoma. Histopathology. 2020;76(5):707–713.
   PubMed Web of Science ®Google Scholar
• Lubitz CC, Economopoulos KP, Pawlak AC, et al. Hobnail variant of papillary thyroid carcinoma: an institutional case series and molecular profile. Thyroid. 2014;24(6):958–965.
   PubMed Web of Science ®Google Scholar
• Watutantrige-Fernando S, Vianello F, Barollo S, et al. The hobnail variant of papillary thyroid carcinoma: clinical/molecular characteristics of a large monocentric series and comparison with conventional histotypes. Thyroid. 2018;28(1):96–103.
   PubMed Web of Science ®Google Scholar
• Elisei R, Viola D, Torregrossa L, et al. The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study. J Clin Endocrinol Metab. 2012;97(12):4390–4398.
   PubMed Web of Science ®Google Scholar
• Baskin Y, Dagdeviren YK, Calibasi G, et al. KRAS mutation profile differences between rectosigmoid localized adenocarcinomas and colon adenocarcinomas. J Gastrointest Oncol. 2014;5(4):265–269.
   PubMedGoogle Scholar
• Eloy C, Santos J, Soares P, et al. The preeminence of growth pattern and invasiveness and the limited influence of BRAF and RAS mutations in the occurrence of papillary thyroid carcinoma lymph node metastases. Virchows Arch. 2011;459(3):265–276.
   PubMed Web of Science ®Google Scholar
• Lino-Silva LS, Domínguez-Malagón HR, Caro-Sánchez CH, et al. Thyroid gland papillary carcinomas with “micropapillary pattern,” a recently recognized poor prognostic finding: clinicopathologic and survival analysis of 7 cases. Hum Pathol. 2012;43(10):1596–1600.
   PubMed Web of Science ®Google Scholar